Search

Your search keyword '"Shields, Bm"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Shields, Bm" Remove constraint Author: "Shields, Bm"
169 results on '"Shields, Bm"'

Search Results

2. Evaluating associations between the benefits and risks of drug therapy in type 2 diabetes: a joint modeling approach

3. What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study

5. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

6. Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

7. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

8. The Lin28/let-7 axis regulates glucose metabolism

9. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype

10. Early growth genetics C. New loci associated with birgh weight identify genetic links between intrauterine growth and adult height and metabolism

11. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis

12. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

13. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes

14. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease

17. A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function

18. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

19. Variants in ADCY5 and near CCNL1 are associated with fetal growth and birth weight

21. Erratum: Corrigendum: Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

22. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.

23. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.

24. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.

26. Genome-wide association study identifies eight loci associated with blood pressure

27. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

28. Genome-wide association study identifies eight loci associated with blood pressure

29. Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease

30. A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function

31. A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

32. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

33. Comment on Garvey et al. Association of Baseline Factors With Glycemic Outcomes in GRADE: A Comparative Effectiveness Randomized Clinical Trial. Diabetes Care 2024;47:562-570.

34. Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach.

35. Comparison of Bayesian approaches for developing prediction models in rare disease: application to the identification of patients with Maturity-Onset Diabetes of the Young.

36. Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosis.

37. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes.

38. Performance of European prediction models for classification of type 1 and type 2 diabetes in Indians.

39. Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study.

40. Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study.

41. Dirichlet process mixture models to impute missing predictor data in counterfactual prediction models: an application to predict optimal type 2 diabetes therapy.

42. Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes.

43. Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy.

44. Genome-wide association study of placental weight identifies distinct and shared genetic influences between placental and fetal growth.

45. Clinical prediction models combining routine clinical measures identify participants with youth-onset diabetes who maintain insulin secretion in the range associated with type 2 diabetes: The SEARCH for Diabetes in Youth Study.

48. Author Correction: Genetic effects on the timing of parturition and links to fetal birth weight.

49. Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine.

50. Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.

Catalog

Books, media, physical & digital resources